NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) HCPCS · Treatment
Classification Treatment › Injections and Infusions (nononcologic) › Erythropoiesis - Stimulating Agent (CMS RBCS)
First observed 2013 — start of our 12-year window; the code predates it
National scale 26.84M services ▼ 27.2% YoY · 29,246 beneficiaries (CY2024, Medicare FFS)
Medicare paid $7.3M · $0.27 avg / service, national
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups

152

Named groups billing this code
Named-group FFS services

22,209,992

Attributable volume · fee-for-service
FFS of Medicare

49%

Payer-mix frame
Services · year over year
Services YoY

-27.2%

FFS enrollment -2.2%
Volume, not care. A shrinking fee-for-service denominator is not a shrinking market.
Estimated all-Medicare volume estimate
FFS + estimated MA

~47,216,227 services

22,209,992 observed fee-for-service (47%) · ~25,006,235 estimated Medicare Advantage.

Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
Top states — Q0138 (CY2024)
FL 10,218,938 TX 3,730,850 CA 1,813,408 MD 1,318,350 IL 1,282,291

Disclosed Medicare fee-for-service services by billing state; open a bar for that state's ranked market.

Billed → allowed → paid
Named-group submitted charges
$86.0M
Named-group allowed amount
$7.8M
Named-group Medicare payments
$6.1M
Avg charge / svc
$4
Avg allowed / svc
$0
Avg payment / svc
$0
Totals are named-group (attributable) sums. Allowed is Medicare’s fee-schedule recognized price — what CMS recognizes, before the 80% Medicare pays.
Average charge per group
$0 152 groups · avg submitted charge / service $15
Market analyticsPlatform Methods →

Search a single state to see that market's full analytics — the free tier previews every panel, gated.

Or just look at it: nuclear heart imaging (78452) in Arizona is open as a live example — the full paid view, real data.

View the live example →
Unlock the Platform — the full read, every number below, code baskets, and export. Looking is free; the depth is paid. Notify me at launch →
Refine: group size any 5+ 25+ 100+ independent only
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022  CY2021  CY2020 
# Physician group City St Specialty Providers Q0138 svcs Submitted charges Avg charge Medicare $ Share* Phone
1 FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC FORT MYERS FL HEMATOLOGY/ONCOLOGY 437 7,085,431 $28,333,309 $4 69.3% (239) 561-9622
2 TEXAS ONCOLOGY PA DALLAS TX PHYSICIAN ASSISTANT 995 2,655,060 $13,278,360 $5 71.2% —
3 ALLISON CURTIS KINGSLEY MEOZ MICHAEL AND SANCHEZ PC LAS VEGAS NV NURSE PRACTITIONER 71 835,380 $5,012,280 $6 88.6% (702) 952-2140
4 ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C PEORIA IL NURSE PRACTITIONER 62 538,200 $2,160,870 $4 42.0% (309) 243-3000
5 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES CA INTERNAL MEDICINE 1424 498,225 $3,175,005 $6 27.5% (310) 825-7922
That's the top 5 of 152 groups. The platform ranks the whole market — code baskets, benchmarks, and the full ranked list. the full ranking is part of the market analytics platform — built, not launched yet. Notify me at launch →

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →